{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:05:42Z","timestamp":1790741142687,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007427","name":"Research Institute for Endocrine Sciences","doi-asserted-by":"publisher","award":["4-43017510"],"award-info":[{"award-number":["4-43017510"]}],"id":[{"id":"10.13039\/501100007427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015995","name":"Nord University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajpc.2026.101408","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:56:23Z","timestamp":1767455783000},"page":"101408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prediction of cardiovascular disease risk in women and individuals with polycystic ovary syndrome using the American Heart Association PREVENT model: A long-term population-based cohort study"],"prefix":"10.1016","volume":"25","author":[{"given":"Parham","family":"Heidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Farrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faegheh","family":"Firouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasamin","family":"Zivari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Ramezani Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3526-640X","authenticated-orcid":false,"given":"Samira","family":"Behboudi-Gandevani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2026.101408_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.825528","article-title":"The prevalence of polycystic ovary syndrome, its phenotypes and cardio-metabolic features in a community sample of Iranian population: Tehran lipid and glucose study","volume":"13","author":"Farhadi-Azar","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101408_bib0002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101408_bib0003","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101408_bib0004","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/cen.12068","article-title":"Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study","volume":"78","author":"Mani","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101408_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2007-992923","article-title":"Cardiovascular disease risk factors in polycystic ovary syndrome","volume":"26","author":"Dokras","year":"2008","journal-title":"Semin Reprod Med"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101408_bib0006","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.mcna.2011.06.002","article-title":"Insulin resistance: the link between obesity and cardiovascular disease","volume":"95","author":"Reaven","year":"2011","journal-title":"Med Clin North Am"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101408_bib0007","doi-asserted-by":"crossref","DOI":"10.2174\/011573403X314035241006185109","article-title":"Insulin resistance, hyperinsulinemia and atherosclerosis: insights into pathophysiological aspects and future therapeutic prospects","volume":"21","author":"Papaetis","year":"2025","journal-title":"Curr Cardiol Rev"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101408_bib0008","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/09513590.2015.1117069","article-title":"Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies","volume":"32","author":"Behboudi-Gandevani","year":"2016","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101408_bib0009","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpc.2026.101408_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/786362","article-title":"Polycystic ovary syndrome: important underrecognised cardiometabolic risk factor in reproductive-age women","volume":"2015","author":"Baldani","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101408_bib0011","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction","volume":"77","author":"Gonz\u00e1lez","year":"2012","journal-title":"Steroids"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101408_bib0012","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1097\/MS9.0000000000000879","article-title":"Vitamin D and polycystic ovary syndrome (PCOS): a review","volume":"85","author":"Mohan","year":"2023","journal-title":"Ann Med Surg (L)"},{"key":"10.1016\/j.ajpc.2026.101408_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100342","article-title":"Ten things to know about ten cardiovascular disease risk factors - 2022","volume":"10","author":"Bays","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2026.101408_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101049","article-title":"Prevalence and long-term outcomes of NAFLD and cardiovascular-kidney-metabolic health in the United States","volume":"23","author":"Liu","year":"2025","journal-title":"Am J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101408_bib0015","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/cen.14284","article-title":"The risk of chronic kidney disease among women with polycystic ovary syndrome: a long-term population-based cohort study","volume":"93","author":"Behboudi-Gandevani","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajpc.2026.101408_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1120119","article-title":"Causal relationship between polycystic ovary syndrome and chronic kidney disease: a mendelian randomization study","volume":"14","author":"Du","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"16","key":"10.1016\/j.ajpc.2026.101408_bib0017","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14219","article-title":"Serum testosterone acts as a prognostic indicator in polycystic ovary syndrome-associated kidney injury","volume":"7","author":"Song","year":"2019","journal-title":"Physiol Rep"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101408_bib0018","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/db05-1484","article-title":"Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion","volume":"55","author":"Parvanova","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpc.2026.101408_bib0019","first-page":"1742","volume":"22","author":"Badawy","year":"2022"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101408_bib0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41043-017-0114-0","article-title":"Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome","volume":"36","author":"Jahangiry","year":"2017","journal-title":"J Health Popul Nutr"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101408_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.23242","article-title":"Performance of the pooled cohort equations to estimate atherosclerotic cardiovascular disease risk by body mass index","volume":"3","author":"Khera","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajpc.2026.101408_bib0022","doi-asserted-by":"crossref","unstructured":"SCORE2 Risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J, 2021. 42(25): p. 2439\u20132454.","DOI":"10.1093\/eurheartj\/ehab369"},{"key":"10.1016\/j.ajpc.2026.101408_bib0023","first-page":"87","volume":"23","author":"Redon","year":"2016"},{"key":"10.1016\/j.ajpc.2026.101408_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/4133365","article-title":"Major limitations of cardiovascular risk scores","volume":"2024","author":"Talha","year":"2024","journal-title":"Cardiovasc Ther"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101408_bib0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","article-title":"The Framingham predictive instrument in chronic kidney disease","volume":"50","author":"Weiner","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101408_bib0026","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/eurjpc\/zwad318","article-title":"Validation of systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in the EPIC-Norfolk prospective population cohort","volume":"31","author":"van Trier","year":"2024","journal-title":"Eur J Prev Cardiol"},{"issue":"17","key":"10.1016\/j.ajpc.2026.101408_bib0027","doi-asserted-by":"crossref","first-page":"E442","DOI":"10.1503\/cmaj.190848","article-title":"Calibration and discrimination of the Framingham risk score and the pooled cohort equations","volume":"192","author":"Ko","year":"2020","journal-title":"Cmaj"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101408_bib0028","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101408_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.38311","article-title":"External validation of the American Heart Association PREVENT cardiovascular disease risk equations","volume":"7","author":"Scheuermann","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4 Suppl","key":"10.1016\/j.ajpc.2026.101408_bib0030","article-title":"Reproductive assessment: findings from 20 years of the Tehran lipid and glucose study","volume":"16","author":"Ramezani Tehrani","year":"2018","journal-title":"Int J Endocrinol Metab"},{"issue":"4 Suppl","key":"10.1016\/j.ajpc.2026.101408_bib0031","article-title":"Contributions and implications of the Tehran lipid and glucose study","volume":"16","author":"Azizi","year":"2018","journal-title":"Int J Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101408_bib0032","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.hjr.0000216552.81882.ca","article-title":"Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran lipid and glucose study","volume":"13","author":"Hadaegh","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ajpc.2026.101408_bib0033","unstructured":"K\/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002. 39(2 Suppl 1): p. S1\u2013266."},{"issue":"10226","key":"10.1016\/j.ajpc.2026.101408_bib0034","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ajpc.2026.101408_bib0035","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2026.101408_bib0036","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.1016\/S2214-109X(24)00210-9","article-title":"Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection","volume":"12","author":"van Daalen","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajpc.2026.101408_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1449058","article-title":"Recommendations for prediction models in clinical practice guidelines for cardiovascular diseases are over-optimistic: a global survey utilizing a systematic literature search","volume":"11","author":"Jing","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"Suppl 1","key":"10.1016\/j.ajpc.2026.101408_bib0038","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/eurheartjsupp\/suae100","article-title":"Cardiovascular risk assessment in daily clinical practice: when and how to use a risk score","volume":"27","author":"Panattoni","year":"2025","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.ajpc.2026.101408_bib0039","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2018.11.001","article-title":"External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: a nationwide registry analysis","volume":"283","author":"Wallisch","year":"2019","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101408_bib0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5334\/gh.1148","article-title":"WHO non-lab-based CVD risk assessment: a reliable measure in a North Indian population","volume":"17","author":"Ananda Selva Das","year":"2022","journal-title":"Glob Heart"},{"key":"10.1016\/j.ajpc.2026.101408_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1077632","article-title":"Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus","volume":"13","author":"Mu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"24","key":"10.1016\/j.ajpc.2026.101408_bib0042","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101408_bib0043","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1464-5491.2000.00221.x","article-title":"Estimating the prevalence of diagnosed diabetes in a health district of Wales: the importance of using primary and secondary care sources of ascertainment with adjustment for death and migration","volume":"17","author":"Morgan","year":"2000","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.ajpc.2026.101408_bib0044","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0735-1097(03)00187-6","article-title":"Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform?","volume":"41","author":"Akosah","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101408_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/M17-3011","article-title":"Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk","volume":"169","author":"Yadlowsky","year":"2018","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101408_bib0046","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/eurjpc\/zwae242","article-title":"External validation and comparison of six cardiovascular risk prediction models in the prospective urban rural epidemiology (PURE)-Colombia study","volume":"32","author":"Lopez-Lopez","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2026.101408_bib0047","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"Bmj"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101408_bib0048","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027011","article-title":"Cardiovascular risk prediction in men and women aged under 50\u2009years using routine care data","volume":"12","author":"van Os","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101408_bib0049","first-page":"170","article-title":"Risk of cardiovascular and cerebrovascular events in polycystic ovarian syndrome women: an updated meta-analysis of cohort studies","volume":"22","author":"Mirzohreh","year":"2025","journal-title":"Turk J Obs Gynecol"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101408_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/cen.13477","article-title":"The risk of metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"88","author":"Behboudi-Gandevani","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101408_bib0051","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.fertnstert.2017.09.004","article-title":"Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study","volume":"108","author":"Kazemi Jaliseh","year":"2017","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101408_bib0052","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12958-025-01346-7","article-title":"Cardiovascular disease risk prediction by Framingham risk score in women with polycystic ovary syndrome","volume":"23","author":"Amiri","year":"2025","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101408_bib0053","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12958-020-00576-1","article-title":"Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"18","author":"Amiri","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101408_bib0054","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101408_bib0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cen.14117","article-title":"The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome","volume":"92","author":"Meun","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101408_bib0056","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ejendo\/lvad077","article-title":"Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria-a prospective population-based cohort study","volume":"189","author":"Ollila","year":"2023","journal-title":"Eur J Endocrinol"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:03:46Z","timestamp":1776207826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"alternative-id":["S2666667726000024"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101408","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of cardiovascular disease risk in women and individuals with polycystic ovary syndrome using the American Heart Association PREVENT model: A long-term population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101408"}}